Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 27,116 | 29,882 | 20,095 | 5,496 | 13,616 |
| Gross Profit | 27,116 | 29,882 | 20,095 | 5,496 | 13,616 |
| Operating Expenses | 56,582 | 65,209 | 46,082 | 27,783 | 28,361 |
| Operating Income | -29,466 | -35,327 | -25,987 | -22,287 | -14,745 |
| Other Income | 3,226 | 3,478 | 4,889 | 7,614 | -839 |
| Pre-tax Income | -26,240 | -31,849 | -21,098 | -14,673 | -15,584 |
| Income Tax | N/A | N/A | N/A | N/A | -3,000 |
| Net Income Continuous | -26,240 | -31,849 | -21,098 | -14,673 | -12,584 |
| Net Income | $-26,240 | $-31,849 | $-21,098 | $-14,673 | $-12,584 |
| EPS Basic Total Ops | -3,190.32 | -4,774.48 | -3,432.34 | -3,322.33 | -3,938.39 |
| EPS Basic Continuous Ops | -3,190.06 | -4,772.51 | -3,432.69 | -3,318.31 | -3,937.93 |
| EPS Diluted Total Ops | -3,190.32 | -4,774.48 | -3,432.34 | -3,322.33 | -3,938.39 |
| EPS Diluted Continuous Ops | -3,190.06 | -4,772.51 | -3,432.69 | -3,318.31 | -3,937.93 |
| EBITDA(a) | $-29,243 | $-35,100 | $-25,887 | $-22,212 | $-14,693 |